NCT03984591View on ClinicalTrials.gov

A Registry-based Cluster Randomized Trial to Compare the Effect of Spironolactone vs. Eplerenone on Clinical Outcomes in Patients With Symptomatic Systolic Heart Failure

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

7,200

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Systolic Heart Failure
Interventions
DRUG

Eplerenone

Eplerenone according to guidelines

DRUG

Spironolactone

Spironolactone according to guidelines

Trial Locations (1)

2400

Bispebjerg Hospital, Copenhagen

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

lead

Bispebjerg Hospital

OTHER